Send me a link:

*Text messaging rates may apply.

 Dow Down0.42% Nasdaq Down0.39%

Neurocrine Biosciences Inc. (NBIX)

-NasdaqGS
13.46 Down 0.12(0.88%) 3:59PM EDT
Balance SheetGet Balance Sheet for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Assets
Current Assets
Cash And Cash Equivalents44,789  63,754  50,107  
Short Term Investments100,950  109,259  78,996  
Net Receivables23  14,089  1,903  
Inventory -   -   -  
Other Current Assets2,700  2,162  1,470  
Total Current Assets 148,462   189,264   132,476  
Long Term Investments -  480   -  
Property Plant and Equipment1,771  1,900  1,586  
Goodwill -   -   -  
Intangible Assets -   -   -  
Accumulated Amortization -   -   -  
Other Assets4,443  4,335  4,306  
Deferred Long Term Asset Charges -   -   -  
Total Assets 154,676   195,979   138,368  
Liabilities
Current Liabilities
Accounts Payable8,056  9,005  9,562  
Short/Current Long Term Debt -   -   -  
Other Current Liabilities3,643  6,641  37,548  
Total Current Liabilities 11,699   15,646   47,110  
Long Term Debt -   -   -  
Other Liabilities2,940  3,249  2,453  
Deferred Long Term Liability Charges19,627  22,712  28,724  
Minority Interest -   -   -  
Negative Goodwill -   -   -  
Total Liabilities 34,266   41,607   78,287  
Stockholders' Equity
Misc Stocks Options Warrants -   -   -  
Redeemable Preferred Stock -   -   -  
Preferred Stock -   -   -  
Common Stock67  66  55  
Retained Earnings(765,763)(719,673)(724,698)
Treasury Stock -   -   -  
Capital Surplus886,101  873,981  784,811  
Other Stockholder Equity5  (2)(87)
Total Stockholder Equity 120,410   154,372   60,081  
Net Tangible Assets 120,410   154,372   60,081  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.